RNA modifications and epitranscriptomics - digital talks
Related
Watch the talks and panel discussion on demand from our first session of 'Epigenetics - From Bench to Clinic'
Summary
Hear leaders in the field present their latest research on RNA modifications and epitranscriptomics. The short web-based meeting is intended to highlight exciting developments in the field and continue the sharing of knowledge within the epigenetics community.
Webinar objectives
- Recognize the importance of the RNA modification m6A in maintaining the function and dynamics of the epitranscriptome
- Deduce the role of the methyltransferase METTL1 in modulating the m7G tRNA modification in oncogenic transformation
- Understand how RNA modifications can regulate gene expression and influence emerging cancer therapies
Deduce the role of the methyltransferase METTL1 in modulating the m7G tRNA modification in oncogenic transformation
Understand how RNA modifications can regulate gene expression and influence emerging cancer therapies
Speakers
- Yanzhong (Frankie) Yang (City of Hope Cancer Center)
- Arginine methylation of METTL14 intrinsically disordered C-terminus by PRMT1 regulates N6-methyladenosine deposition
- Abdulkadir Abakir (Babraham Institute)
- The role of N6-methyladenosine (m6A) in R-loop biology
- Samie Jaffrey, Cornell University
- Understanding the function and dynamics of m6A in the epitranscriptome
- Richard Gregory, Harvard Medical School
- METTL1-mediated m7G tRNA modification drives oncogenic transformation
- Chuan He, University of Chicago
- RNA methylation in gene expression regulation and cancer therapies.
Moderator:
- Tony Kouzarides, University of Cambridge
Contact
Have a question? Please contact the Abcam Events Team.